A retrospective analysis of treatment patterns, drug discontinuation and healthcare costs in Crohn's disease patients treated with biologics-Reference-Cited by-同舟云学术

A retrospective analysis of treatment patterns, drug discontinuation and healthcare costs in Crohn's disease patients treated with biologics

Published:2023-09 Issue:9 Volume:55 Page:1214-1220
ISSN:1590-8658
Container-title:Digestive and Liver Disease
language:en
Short-container-title:Digestive and Liver Disease

Author:

Degli Esposti Luca,Daperno Marco,Dovizio Melania,Franchi Andrea,Sangiorgi Diego,Savarino Edoardo Vicenzo,Scaldaferri Franco,Secchi Ottavio,Serra Andrea,Perrone Valentina^ORCID,Armuzzi Alessandro

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference28 articles.

1. Inflammatory bowel disease: pathophysiology and current therapeutic approaches;Abraham;Handb Exp Pharmacol,2017

2. Crohn's disease;Torres;Lancet,2017

3. Clinical course in Crohn's disease: results of a Norwegian population-based ten-year follow-up study;Solberg;Clin Gastroenterol Hepatol,2007

4. American Gastroenterological Association Institute Guideline on the Use of Thiopurines, Methotrexate, and Anti–TNF-α Biologic Drugs for the Induction and Maintenance of Remission in Inflammatory Crohn's Disease

5. The economic and quality-of-life burden of Crohn's disease in Europe and the United States, 2000 to 2013: a systematic review;Floyd;Dig Dis Sci,2015

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lipid- and polymer-based formulations containing TNF-α inhibitors for the treatment of inflammatory bowel diseases;Drug Discovery Today;2024-08

2. Aryl Hydrocarbon Receptor Regulates Muc2 Production Independently of IL-22 during Colitis;International Journal of Molecular Sciences;2024-02-18

3. Importance of age, complications, progression, and risk factors in Crohn's Disease management with biologics;Digestive and Liver Disease;2024-01

4. Author's Reply: “A retrospective analysis of treatment patterns, drug discontinuation and healthcare costs in Crohn's disease patients treated with biologics”;Digestive and Liver Disease;2024-01

5. Treatment patterns and factors associated with discontinuation of monoclonal antibodies;SAGE Open Medicine;2024-01